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Abstract
Background: The laboratory rat (Rattus norvegicus) is one of the preferred model organisms in
physiological and pharmacological research, although the availability of specific genetic models,
especially gene knockouts, is limited. N-ethyl-N-nitrosourea (ENU)-driven target-selected
mutagenesis is currently the most successful method in rats, although it is still very laborious and
expensive.
Results: As ENU-induced DNA damage is normally recognized by the mismatch repair (MMR)
system, we hypothesized that the effectiveness of the target-selected mutagenesis approach could
be improved by using a MMR-deficient genetic background. Indeed, Msh6 knockout rats were found
to be more sensitive to ENU treatment and the germ line mutation rate was boosted more than
two-fold to 1 mutation per 585 kb. In addition, the molecular mutation spectrum was found to be
changed in favor of generating knockout-type alleles by ~20%, resulting in an overall increase in
efficiency of ~2.5 fold. The improved effectiveness was demonstrated by high throughput mutation
discovery in 70 Mb of sequence in a set of only 310 mutant F1 rats. This resulted in the identification
of 89 mutations of which four introduced a premature stopcodon and 64 resulted in amino acid
changes.
Conclusion: Taken together, we show that the use of a MMR-deficient background considerably
improves ENU-driven target-selected mutagenesis in the rat, thereby reducing animal use as well
as screening costs. The use of a mismatch repair-deficient genetic background for improving
mutagenesis and target-selected knockout efficiency is in principle applicable to any organism of
interest.
Background
The rat is one of the most widely used model organism in
biomedical research and has proven to be a powerful tool
for linking physiology and pathology to the genome [1,2].
Selective breeding and characterization of strains, mim-
icking complex human diseases have led to hundreds of
useful models. However, identification of the underlying
causative polymorphisms and genes has shown to be dif-
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ficult. An alternative approach in elucidating specific gene
functions is by introducing targeted genetic modifica-
tions. Gene knockout technology using homologous
recombination in embryonic stem cells has proven to be
extremely powerful for this [3]. However, due to the lack
of pluripotent embryonic stem cells for the rat, ENU-
driven target-selected mutagenesis, also known as TILL-
ING [4] has been one of the most successful methods for
generating knockouts in the rat [5,6]. This approach does
not require any special cell lines and/or advanced oocyte
or embryo manipulation as male animals are injected
with the alkylating agent ENU, which very efficiently
introduces random point mutations in the DNA of sper-
matogonial stem cells. Upon crosses with untreated
female animals, an F1 generation is established in which
each individual carries different random heterozygous
point mutations in its genome. The DNA of these animals
is subsequently screened in pre-selected genes of interest
with the goal to identify mutations that affect protein
function, e.g. by introducing a premature stopcodon, by
changing a consensus splice site residue, or by mutating
critical (conserved) amino acids.
The overall efficiency of this method depends essentially
on the mutagenicity of ENU, which was found to be both
strain and dose dependent [5-7]. The maximum ENU-
induced mutation rate in rats is approximately one point
mutation every 1.25 – 1.5 Mb for Wistar rats treated with
35–40 mg ENU per kg bodyweight [5], which is similar to
the highest mutation frequency that can be obtained in
mice [8-12]. Higher doses of ENU result in sterility of the
animals and at much higher doses (>120 mg/kg for rats)
in lethality. However, in Arabidopsis and C. elegans chem-
ically induced (EMS) point mutation frequencies are as
high as 1 in 100 kb [13,14] and in zebrafish ENU-induced
frequencies of 1 in 150–250 kb can be obtained routinely
[15] (E.C., unpublished results), suggesting that the max-
imum mutation load in a vertebrate genome that is com-
patible with viability, is much higher than what is
currently reached in both rat and mouse. Although about
10 rat knockouts were successfully generated by ENU-
driven target-selected mutagenesis [5,6,16] the relatively
low mutation frequency makes the target-selected muta-
genesis procedure laborious and costly.
We hypothesized that the efficiency of the ENU-driven
target-selected mutagenesis approach could potentially be
increased in a MMR-deficient genetic background, as this
system is involved in the response to and repair of ENU-
induced genetic damage [17]. Single nucleotide mis-
matches, as well as small insertion and deletion loops
(IDLs), are recognized by MutSα heterodimer, which con-
sists of Msh2 and Msh6 [18]. Because Msh2 also functions
in another heterodimer with Msh3, which recognizes
larger IDLs, Msh6-deficiency is in principle best suited to
test the idea if the ENU mutagenesis efficiency can be
increased in a MMR-deficient background. The MutSα
subunit has already been implicated in the recognition of
different forms of DNA damage caused by genotoxic
agents [19]. Indeed, cell lines deficient in MutSα function
that were treated with different alkylating agents, includ-
ing ENU, showed a higher survival and increased muta-
tion rate [17].
A rat carrying a premature stopcodon in the Msh6 gene has
been identified in a previous knockout screen in our lab
[5]. This mutation was shown to result in a complete loss
of function [20] and, as a result, these animals show
genetic instability as indicated by microsatellite instability
(MSI), an elevated spontaneous germ line point mutation
rate and tumorigenesis [20].
Here, we show that Msh6-deficiency improves the effi-
ciency of the ENU-driven target-selected mutagenesis pro-
cedure in the rat by ~2.5-fold. This does not only result in
a vast decrease of the number of animals needed, but
equally reduces screening costs.
Results
Effect of ENU in Msh6 knockout rat
The efficiency of ENU is both strain and dosage-depend-
ent, which is reflected by very large differences in muta-
tion frequency in different mouse [7] and rat [5,6] inbred
strains and by a higher mutagenicity after three weekly
administrations of low doses of the mutagen as compared
to a single high-dose injection [7]. Higher ENU concentra-
tions not only increase the mutation frequency, but also
affect fertility [5,21]. To determine the optimal concentra-
tion in the msh6-/- rat (which is in Wistar background), we
performed a dose-response experiment and determined
the impact of the mutagen on fertility. At 12 weeks of age
msh6-/- males were treated with 3 weekly doses of ENU
ranging between 1 and 35 mg/kg bodyweight and fertility
was monitored after a full cycle of spermatogenesis (~60–
70 days). At concentrations of 35 and 30 mg/kg, respec-
tively 1 out of 8 and 5 out of 8 males were fertile (Table
1). Previous studies showed that wild type Wistar rats are
less sensitive to ENU as 6 out of 10 and 10 out of 10 rats
were fertile at 40 and 35 mg/kg ENU, respectively [5].
We also found that ENU affects the survival of msh6-/- rats.
Untreated msh6-/- rats show a median survival of 60 weeks
[20], while ENU treatment decreased survival of mutant
males to an average mean of 37 ± 3 weeks (Figure 1). This
decrease in lifespan was found to be due to tumor devel-
opment, mainly lymphomas (data not shown). It is cru-
cial for performing ENU target-selected mutagenesis
screens that animals are viable and healthy for at least 26
weeks to allow for mutagenesis and subsequent breeding.
In previous studies, no reduction in lifespan was observedBMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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in both 40 mg/kg (10 out of 10 survived) and 35 mg/kg
(9 out of 10 survived) ENU-treated wild type males until
1.5 years of age (E.C., unpublished data).
Mutation screening procedure
We have developed an automated, high-throughput and
cost-effective dideoxy-based DNA resequencing protocol
(~0.15 € for chemicals and disposables per sample) for
the discovery of ENU-induced point mutations [5]. To
reduce the costs of the knockout procedure further, we
now established an efficient breeding and screening
schedule in which the offspring of mutagenized animals
are screened for the presence of interesting mutations
before they are weaned (3 weeks of age). This rolling-circle
model significantly reduces the amount of animal space
needed.
At two weeks of age tissue samples from uniquely tagged
F1 offspring were taken and DNA was isolated. Subse-
quently, DNA samples were screened for 768 pre-selected
amplicons by nested PCR amplification and sequencing
using two sets of 384 wells plates, containing pre-gridded
primers. Resequencing data for the same amplicons from
different pups were automatically processed by PolyPhred
[22] as well as semi-manually inspected using in-house
developed software. All candidate mutations were verified
in independent PCR and sequencing reactions and within
one week interesting mutants could be selected and
weaned.
Increased ENU mutagenicity in Msh6-deficient 
background
The highest ENU dose resulting in more than 25% fertile
males after a full cycle of spermatogenesis was found to be
3 × 30 mg/kg for the msh6-/- background. In wild type Wis-
tar rats this dose was 3 × 40 mg/kg [5,21] and in SD and
F344 2 × 60 mg/kg [6]. We screened 768 amplicons in 291
F1 progeny of the 3 × 30 mg/kg group and covered ~70
Mb of sequence. A total of 84 ENU-induced mutations
were identified (Table 1). As a result, the overall mutation
rate is 1 mutation every 8.29 × 105 bp, a 1.5-fold increase
compared to the highest mutation rate in Msh6-proficient
animals.
Only one nest of three pups could be recovered from the
single fertile male that was treated with 3 × 35 mg/kg (this
animal was sterile in subsequent mating) and one muta-
tion was discovered in the 0.72 Mb that was sequenced
(Table 1). 16 F1 progeny from a single male that was
treated with 25 mg/kg were screened and in this group 4
mutations were discovered in 3.6 Mb, resulting in a simi-
lar mutation rate as observed in the 3 × 30 mg/kg treated
group (Table 1).
Although several candidate mutations were found more
than once, though at low frequency, analysis of family
relationship revealed that these are not due to clonal
effects, as in all cases, F1 progeny bearing the same muta-
tions descended from different founders. These polymor-
phism where thus classified as low frequency SNPs (note
that Wistar is an outbred strain) and not included in the
results. Unfortunately, mutation density in our study is
not high enough to draw any conclusions on the existence
of hypersensitive or ENU-resitant regions in the rat
genome.
Mutation frequency changes over time
We analyzed the mutation frequency of the F1 offspring in
time bins after mutagenesis of the founders. Offspring
from mutant males treated with 3 × 30 mg/kg demon-
strate a reduction of mutation frequency in time (Figure
2a). In the 79 animals that were born 14 – 17 weeks after
Table 1: ENU-induced mutation frequencies
Genotype/Dosea Msh6-/-3 × 25 Msh6-/-3 × 30 Msh6-/-3 × 35 Total WT Control 3 × 40b
# Males injected 688 2 4 1 0
# Fertile malesc N/D 5 1 6
# Pups for screening 16 291 3 310 362
# Bases screened 3.6 × 106 69.7 × 106 0.7 × 106 74.0 × 106 37.3 × 106
# Mutations
- nonsense 040 4 0
- missense 45 91 6 4 1 7
- silent 01 60 1 6 7
- non-coding 050 5 6
- total 48 41 8 9 3 0
Mutation Frequencies (bp-1) 1.12 × 10-6 1.21 × 10-6 1.38 × 10-6 8.05 × 10-7
Mutation Rates (bp) 1 in 8.93 × 105 1 in 8.29 × 105 1 in 7.22 × 105 1 in 12.4 × 105
aDose is indicated as mg of ENU per kg bodyweight (three weekly injections)
bWT (Wild Type) control 3 × 40 mg/kg measurements were adapted from [5] and represent the highest ENU-induced mutation frequency in rats
cFertility is measured by the presence of at least one litter within 10 weeks after the last injection.
Sterility was confirmed by histological examination (N/D = not determined)BMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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the last ENU injection ~18.7 Mb was analyzed and 32
mutations were discovered, reflecting a mutation fre-
quency of 1.71 × 10-6 per bp and a rate of 1 mutation every
585 kb. Animals that were born 18 – 21 weeks and 22 –
25 weeks after the last ENU injection show a decreased
mutation frequency of 1.30 × 10-6 and 0.74 × 10-6 per base
pair, respectively. We observed some notable variation in
germ line mutation frequencies between the 5 founders.
However, this was mainly the result of the differences in
litter sizes at the analyzed time points and the variation
decreased almost completely when the overall germ line
mutation frequency of the individual founders was com-
pared (1.20 × 10-6 ± 0.25 × 10-6), suggesting only limited
inter-animal variability. F1 progeny born later than 25
weeks after the last injection show a slight increase in fre-
quency (~1.0 × 10-6 per bp). However, this observation is
based on a relatively low numbers of F1 progeny, derived
from a limited number of founders, as the mortality
started to increase at this time. The mean survival of ENU-
treated msh6-/- rats (3 × 30 mg/kg) was 37 ± 3 weeks, which
is 23 weeks after the last injection (Figure 1). Notably, all
fertile males lived at 37 weeks of age, while the infertile
males had mostly died, suggesting a direct relationship
between fertility and viability, and probably also the
amount of ENU-induced genetic damage.
ENU-induced mutation spectrum differs in Msh6-deficient 
background
Interestingly, it was found that ENU induces a different
mutation spectrum in an Msh6-deficient background as
compared to an MMR-proficient background (Figure 2b).
The most common mutations in both wild type as well as
Msh6-deficient background were alternations of A-T base
pairs (~75%). This is consistent with previous reports and
Effect of ENU on the survival of msh6-/- males Figure 1
Effect of ENU on the survival of msh6-/- males. Msh6-/- male rats show an increased mortality after treatment with differ-
ent concentrations of ENU compared to untreated msh6-/- male rats. Survival of untreated and ENU-treated wild type rats is 
100% in the indicated time-period (data not shown). Red arrowheads indicate the time points of the last ENU injection and the 
start of mating for F1 progeny that can be screened for mutations without risk for chimaeric progeny.BMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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ENU-induced mutation frequency and spectrum Figure 2
ENU-induced mutation frequency and spectrum. (a) The ENU-induced mutation frequency differs in time. Red circles 
indicate the mutation frequency of the F1 progeny of the 5 different msh6-/-founders treated with 30 mg ENU/kg. The black 
stripes indicate the mutation frequency of all the F1 progeny of these founders together for the different time bins. A decrease 
of mutation frequency is observed in time, which reaches a steady level at 1.0 × 10-6 per bp (1 mutation per 1 Mb). The letter 
n indicates the number of total F1 screened per time bin. (b) ENU-induced mutation spectrum in Msh6-deficient background 
(white bars) compared to MMR-proficient animals (black bars).BMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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is thought to result from O2-ethylthymine (O2-etT) and
O4-ethylthymine (O4-etT) lesions [17,23]. However, for
the A-T pairs a significant increase in A-T to T-A transver-
sions (p = 0.045) and decrease of A-T to G-C transitions (p
= 0.019) was observed in the Msh6-deficient background.
It has been shown that bypass of O2-etT lesions induces A-
T to T-A transversions, whereas O4-etT lesions results in A-
T to G-C transitions [24,25]. Our data suggests that MutSα
preferentially recognizes O2-etT lesions in the rat.
Due to non-random codon usage and the highly biased
composition of translation termination codons, the
chance for introducing a premature stopcodon strongly
depends on the mutation spectrum. For example, A-T to T-
A transversions can introduce a premature stopcodon in 7
out of the total 183 possible changes in the genetic code
(excluding the combinations that already code for a stop
signal), whereas A-T to G-C transitions will never result in
a premature stopcodon. Based on the mutation spectra
obtained in wild type and Msh6-deficient backgrounds we
calculated the chance of generating a knockout-type allele
by introducing a premature stopcodon or mutating splic-
ing donor/acceptor site for the 768 amplicons that were
used in our screen. The chance of generating a knockout-
type allele was found to be increased by ~21% in the
MMR-deficient background (from 4.26% for wild type to
5.16% for the msh6-/- mutation spectrum).
ENU-induced mutations
The 768 amplicons that were used in the mutation screen-
ing were designed to cover exons of genes of interest. 84
out of the 89 mutations that were identified reside in pro-
tein-coding regions (Table 1). Four mutations (~5%)
introduce a premature stopcodon in an open reading
frame and are thus most likely to result in a functional
knockout of the gene, which corresponds nicely with the
expected chance of introducing a premature stopcodon, as
discussed above. 64 mutations cause an amino acid
change (missense, ~76%) and 16 mutations do not affect
protein coding (silent, ~19%), which also correspond
with calculated predictions (74% and 22%, respectively).
None of the non-coding mutations resided in splicing
donor/acceptor sites.
Discussion
The mutagen ENU can transfer its ethyl group to oxygen
or nitrogen radicals present in DNA, which results in
lesions that can cause mispairing during replication and
eventually give rise to a single base pair substitution [23].
We hypothesized that a deficiency in the repair system
that detects or corrects such single base pair damages or
mismatches would result in an increased ENU-induced
mutation frequency and associated improvement of the
target-selected mutagenesis-based knockout procedure.
Indeed, deficiency of Msh6 was found to improve the
ENU-driven knockout procedure in two ways; 1) it
increases the ENU-induced germ line mutation frequency
up to 1 mutation every 585 kb and 2) the mutation spec-
trum is changed and enhances the chance of generating a
knockout-type allele by 21%. Cumulatively, this results in
a ~2.5-fold increase in knockout efficiency.
The increased mutation frequency was reached at an ENU
dose that was 25% lower than in wild types and together
with the change in mutation spectrum this argues for the
specificity of MMR-deficiency underlying the observed
effects. In line with this, an increase in mutagenicity of
ENU in MMR-deficient background was also shown in
mouse ES cells lacking Msh2 [17]. However, it has to be
noted that in zebrafish, which lack Msh6, no difference in
ENU-induced mutation frequency has been observed
compared to MMR-proficient fish [26]. This apparent con-
tradiction with the results presented here could be
explained by the large difference in mutation frequency.
In wild type zebrafish, the ENU-induced mutation fre-
quency is about 1 mutation every 100,000 bp, whereas,
this frequency in wild type rats is more than 10-fold lower
[5,8-12]. Proposedly, the zebrafish mutation load is the
maximum that is compatible with viability, a suggestion
that is corroborated by comparable maximal mutation
frequencies observed in C. elegans [13] and Arabidopsis
[14]. Our results suggest that the lower ENU-induced
mutation frequencies in rodents can at least partially be
explained by more efficient mismatch repair in the testis
that counteracts mutagenicity, and is less likely due to
increased sensitivity to genotoxic damage in general. The
decline of the mutation frequency in time that is observed
in this study, however, could indicate the presence of gen-
otoxic effect. Initial depletion of spermatogonial stem
cells could be due to apoptosis induced by ENU damage
– a mechanism that is presumed to be underlying the ste-
rility effect at higher doses. Selective repopulation of the
testis by the most viable stem cells with presumably the
lowest amount of genotoxic damage, decreases the appar-
ent mutation frequency (and potentially increases the
change for clonal progeny). Our results indicate that the
target-selected mutagenesis works most efficient for F1
progeny resulting from matings at about 10 – 14 weeks
after the last ENU injection. However, it should be kept in
mind that only F1 animals, generated after one full cycle
of spermatogenesis (in rat and mouse about 60 to 70
days) after mutagenesis, should be screened in order to
prevent retrieval of chimaeras. Such chimaeras can be
induced by ethyl-DNA adducts in the fertilized oocyte that
originate from mutagenized post-meiotic sperm cells and
which could result in fixation of mutation in different lin-
eages during embryonic development.
Besides the ENU mutagenesis approach, other gene target-
ing technologies are being developed for the rat, whichBMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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include nuclear transfer, although to date no genetic mod-
ification has been reported, and knockdown by RNA
interference (reviewed in [27]). Recently, transposon-
tagged mutagenesis [28] was successfully applied to the
rat [29] as well and although this technique is currently
less amendable for scaling, it should be considered as
highly complementary to the existing ENU-based efforts.
The ENU-driven target-selected mutagenesis approach has
already been used successfully for generating a variety of
novel rat knockout models [5,6,16] and with the improve-
ments described here, this approach does provide realistic
technological requirements for screens on a genome-wide
scale. In a wild type background, ~110,000 F1 rats would
be needed to knockout any given gene with 95% probabil-
ity (Figure 3). This number is reduced to 40,000 in the
MMR-deficient background. When reasoning the other
way around, 40,000 F1 rats will contain knockouts of
95% of all rat genes and when considering 'only' 5,000 F1
rats, knockout alleles for ~50% of all the rat genes will be
present. It should be said, however, that to identify these
knockout alleles, the complete ORFeome would have to
be screened. Although existing technologies are not suited
for this, emerging massively parallel sequencing technol-
ogies [30], and microarray-based enrichment procedures
[31,32] provide promising avenues in this direction.
Keeping this in mind, archiving frozen sperm samples of
mutant F1 animals, which can be recovered by intracyto-
plasmic sperm injection (ICSI) [33,34] becomes very
attractive.
The identification of a wide range of potentially interest-
ing missense mutations as well as the retrieval of four
novel candidate knockout models resulting from the
introduction of premature stopcodons by screening only
a small set of about 300 animals illustrates the power of
the approach. Furthermore, the ENU-based approach has
the potential to generate allelic series (multiple mutations
in the same gene) in different animals, which can facilitate
the identification of novel gene functions. For example,
hyper- and hypomorphic mutations provide information
related to gene dosage effects and residues important for
specific protein interactions or enzymatic functions can be
identified.
Probability of gene knockouts in Msh6-deficient and wild type rats Figure 3
Probability of gene knockouts in Msh6-deficient and wild type rats. The chance to retrieve a knockout for any given 
gene and the total number of genes that will be knocked out when all genes would be screened for mutations is plotted as a 
function of the number of mutant F1 animals for wild type (WT, 40 mg ENU/kg, black line) and MMR-deficient (Msh6-/-, 30 mg 
ENU/kg, red line) rats. The red dashed lines show the number of animals needed to knockout 95% of all genes and any given 
gene with 95% chance. The use of a Msh6-deficient background reduces the number of animals ~2.5-fold.BMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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Currently, the 4 knockouts and 45 selected missense
mutations are being crossed to the next generation and
bred to homozygosity for subsequent phenotypic analy-
sis. As homozygous Msh6-deficiency, which could occur
in later generations, would result in further accumulation
of novel mutations, this outcross is also used to eliminate
the mutant msh6 allele from the genetic background by
genotype-assisted breeding. In addition, further outcross-
ing to wild type background should be performed and lit-
termates should be included as control animals in
phenotypic characterization experiments to minimize
confounding effects of background mutations. Although
such effects should never be ignored, estimates do indi-
cate that this potential problem should not be exaggerated
[35], especially if outcrossing is combined with marker-
assisted selection for which the outbred Wistar back-
ground is well-suited.
Conclusion
We have significantly improved the target-selected muta-
genesis gene knockout technology for rats by taking
advantage of deficiency of specific MMR function. As
mutagen-driven target-selected mutagenesis approaches
have become popular in organisms for which no ES cell-
based techniques are available, such as medaka [36], but
also plants like rice [37], Lotus [38] and maize [39], the
improvements described here may equally well be applied
to other species for optimization of gene knockout effi-
ciency.
Methods
Animals and ENU mutagenesis protocol
All experiments were approved by the Animal Care Com-
mittee of the Royal Dutch Academy of Sciences according
to the Dutch legal ethical guidelines. Experiments were
designed to minimize the number of required animals
and their suffering. Male Msh6 knockout rats (Msh61Hubr)
of 12 weeks of age were given three weekly intraperitoneal
injections of 1, 5, 10, 20, 25, 30 and 35 mg ENU/kg bod-
yweight. Preparation of ENU (Isopac; Sigma) was done as
described [5]. Injected males were monitored for fertility
by breeding with one or two females, starting 3 weeks
after the last mutagenesis treatment. Pups from these early
matings were counted, but not analyzed. Ten weeks after
the last injection, fertile males of the highest-dosed fertile
group were kept on a weekly breeding scheme with two
females to produce F1 progeny for mutational analysis.
Animals were housed under standard conditions in
groups of two to three per cage per gender under control-
led experimental conditions (12-h light/dark cycle, 21 ±
1°C, 60% relative humidity, food and water ad libitum).
Genomic DNA isolation, PCR and sequencing conditions
At two weeks of age F1 progeny were uniquely tagged by
ear clipping and the resulting tissue fragments were lysed
as described [5], followed by phenol/chloroform (1:1,
vol/vol) extraction. DNA was precipitated by adding 300
μl isopropanol, mixing and centrifuging for 20 min, at
21,000 g at 4°C. The supernatant was discarded and pel-
lets were washed with 70% ethanol and dissolved in 500
μl 10 mM Tris-HCl (pH 8.0). 768 pre-selected amplicons
were amplified using a nested PCR setup as described [5]
with the following modifications. The first PCR reaction
was carried out in 2 × 384 wells plates per F1 animal sam-
ple, in a total volume of 5 μl, and every well contained a
unique set of primers (0.2 μM of each). After thermocy-
cling, the PCR1 reactions were diluted with 20 μl H2O and
1 μl was used as template for the second round of PCR,
which was carried out in the same 2 × 384 wells format as
the first PCR, however, with different sets of primers
which are internal to the first set (nested). Sequencing
reactions contained 0.1 μl BigDye (v3.1; Applied Biosys-
tems), 1.9 μl BigDye Dilution Buffer (Applied Biosystems)
and 0.4 μM of the forward primers used for the PCR2 reac-
tion in a total volume of 5 μl. After thermocycling purified
sequencing products were analyzed on a 96-capillary
3730XL DNA analyzer (Applied Biosystems), using the
standard RapidSeq protocol on 36 cm array. Sequences
were analyzed for the presence of heterozygous mutations
using PolyPhred [22] and in-house developed software.
All candidate mutations were verified in independent PCR
and sequencing reactions.
Project management and primer design using LIMSTILL
All resequencing projects were designed and managed
using LIMSTILL, LIMS for Induced Mutations by Sequenc-
ing and TILLing (V.G., E.C., unpublished). This web-
based publicly accessible information system http://lim
still.niob.knaw.nl was used to generate projects and visu-
alize gene structures based on Ensembl genome data, the
design of PCR primers, entry, archiving and primary inter-
pretation of mutations. The primer design application
within LIMSTILL is Primer3-based [40] and parameters
are set to design primers with an optimal melting temper-
ature of 58°C.
Knockout probability calculation
Calculation of the frequency of introducing a premature
stopcodon with different mutation spectra is an integrated
feature of LIMSTILL http://limstill.niob.knaw.nl. The
chance of generating a knockout-type allele was calculated
for all 768 working amplicons by comparing the probabil-
ity of nonsense mutations and splicing donor/acceptor
mutations divided by all changes in coding sequence plus
splicing donor/acceptor sites (first two and last two nucle-
otides of each intron), all corrected for the wild type and
mutant mutation spectra. To calculate the knockout prob-BMC Genomics 2008, 9:460 http://www.biomedcentral.com/1471-2164/9/460
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ability both the mutation frequency and corresponding
spectrum were taken into account. Rat Ensembl Build
47.34q was downloaded from ftp.ensembl.org. For every
gene the longest transcript (22,959 in total) was used to
calculate the total number of coding nucleotides. Wistar
animals treated with 40 mg/kg ENU represent the most
optimal wild type group and were compared with F1
progeny from msh6-/- animals that was born 14 – 17 weeks
after the last ENU injection.
Statistical analysis
For calculating statistical differences in the mutation spec-
trum data the chi-squared test was used. P < 0.05 was con-
sidered to be statistically significant.
Abbreviations
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